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1. Introduction 
Atractyloside is known to be a competitive 
[ 1,2] and specific inhibitor of the adeninenucleo- 
tide translocation [2-81 across the inner [9-l l] 
mitochondrial membrane. In the course of extract- 
ing atractyloside from the thistle A tructylis gummi- 
fem. another glycoside having solubility properties 
similar to those of atractyloside was isolated [ 121. 
Until its structure and its possible relationship to 
atractyloside could be definitively established we 
proposed to name it gummiferin [ 121. 
In this report gummiferin is shown to be as po- 
tent and specific an inhibitor of the ADP-trans- 
location as atractyloside. But whereas the inhibition 
of the ADP-translocation by atractyloside isreversed 
by high ADP concentrations, the gummiferin-depen- 
dent inhibition is not. The binding properties of 
(3SS)-gummiferin to rat liver mitochondria were 
compared to those of (35S)-atractyloside taken as 
reference [1 I] . The fractional saturation of mito- 
chondria with gummiferin was found to parallel the 
fractional inhibitory effect of gummiferin on the 
ADP translocation; both the inhibition curve and 
the saturation curve are sigmoidal. The strong co- 
operative interactions observed uring (3sS)gummi- 
ferin binding - up to saturation - are increased by 
added ADP and decreased by atractyloside, but 
neither ADP nor atractyloside alter the number of 
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Fig. 1. Chromatographic and electrophoretic separation of 
atractyloside (Atr), apo-atractyloside (Ape-Atr), gummiferin 
(Gum), apo-gummiferin (Ape-gum), desulphated atractyloskle 
and desulphated gummiferin. The spots give a pink color with 
vanihin [ 131 (spray: 0.5 g of vanillin in 50% phosphoric acid). 
(A) Descending chromatography on Whatman no. 3 paper in 
n-butanol/acetic acid/water, 4:1:5, by vol., 18 hr. Mean of the 
RF values: atractyloside: 0.72, gummiferin: 0.60, apo-atractyl- 
oside: 0.45, apo-gummiferin: 0.35. (l3) Electrophoresis on 
Whatman no. 3 paper for 1 hr in pyridin/acetic acid/water, 
0.65:2.5: 1250, by vol., 66 V/cm, in a Pherograph apparatus. 
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Fig. 2. (A) Mass spectrometry spectrum of silylated and acetylated atractyloside. 
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Fig. 2. (B) Fragmentation of silylated and acetylated atrac- 
tyloside observed in mass spectrometry. The free hydroxyl 
groups of atractyloside were acetylated by acetic anhydride 
in pyridin prior to displacing the two sulphate groups by a 
silylating mixture (pyridine/hexamethyldisilazane trimethyl- 
chlorosilane). AEI (MS-g) Mass Spectrograph. 
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Fig. 3. Effect of atractyloside (Atr) and gummiferin (Gum) 
on the ADP-stimulated respiration of mitochondria. The 
reaction medium contained 110 mM KCl, 16 mM phos- 
phate buffer (ph 7.4), 6 mM MgCla, 10 mM glutamate and 
4 mg of mitochondrial protek; other additions: ADP, 
atractyloside, gummiferin, carbonyl cyanide-p-trifluoro- 
methoxyphenylhydrazone (FCCP) as indicated on the 
traces. Final volume 2 ml. Temperature 25”. 
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Fig. 4. Inhibition, by gummiferin, of the phosphorylation of 
added (r4C)-ADP as contrasted with the absence of effect on 
the phosphorylation of internal adeninenucleotides. Mito- 
chondria (17 mg of protein) were incubated at 2” in 110 niM 
KCI, 10 mM phosphate, 0.1 mM EDTA and 0.5 mM ( t4C)- 
ADP. Gummiferin where present was 5 PM, pH was 7.4 and 
the total volume 4.0 ml, The incubation was ended by addi- 
tion of perchloric acid to a final concentration of 2%. After 
neutralization of the extracts, the amounts of AMP, ADP 
and ATP were determined according to Adam [ 161. The 
increase of phosphate bonds in adenine nucleotides (-P) was 
determined as the increase of the sum: ADP + 2 ATP. La- 
belled adenine nucleotides arising from (t4C)-ADP added 
to mitochondria were separated by paper chromatography 
[ 171 and located under UV light. Their respective areas were 
cut out for determination of their radioactivky by means of 
a thin window gas flow counter. 
gummiferin binding sites. On the contrary, bong- 
krekic acid produces a netpdecrease of the number 
of gummiferin binding sites without interfering sig 
nificantly with the co-operative interactions. 
2. Results 
2.1. Isolation and characterization of gummifetin 
Gummiferin which is recovered together with 
atractyloside from extracts [ 121 of the rhizomes 
of the thistle Atractylisgummifera can be separated 
from atractyloside by paper chromatography or elec- 
trophoresis [ 121 (fig. 1). Gummiferin contains sul- 
fur in its molecule and this allowed the isolation of 
(35S)-gummiferin from plants that had been grown 
in the presence of (35S)sulfate. (3sS>gummiferin 
recovered from electrophoregrams by elution was 
estimated by determination of the 5% inhibition 
of either the ADP-itimulated respiration or the ADP 
translocation (see below) after having calibrated the 
systems with purified gummiferin. The specific radio- 
activity of (35S)gummiferin (and (3sS)-atractyloside) 
used in this work ranged from 0.3 to 1 X lo6 dpm/ 
pmole. 
Glucose is the only sugar released by total hydro- 
lysis of gummiferin. To further analyze the structure 
of gummiferin, two types of derivatives were pre- 
pared from gummiferin and atractyloside: (1) the 
apo-derivatives (nomenclature proposed by Piozzi 
et al. [ 141 obtained by removal of isovaleric acid 
by barium hydroxide in dry methanol); (2) the de- 
sulphated derivatives obtained by removal ot the 
sulphate groups [ 151. Fig. 1 shows the chromato- 
graphic and electrophoretic behaviour of those com- 
pounds: as for gummiferin with regards to atractyl- 
oside, apo-gummiferin is slightly more polar and _. 
more negatively charged at pH 4.5 than apoatractyl- 
oside; on the contrary, in these conditions, the mi- 
grations of the de-sulphated derivatives of atractyl- 
oside and of gummiferin are similar. The mass spec- 
trum obtained from gummiferin is the same as that 
of atractyloside (fig. 2) [ 151, a result which indicates 
that the carbon skeleton of the two compounds is 
the same. 
2.2. Gummiferin as an inhibitor of the ADP trans- 
location in mitochondti 
As shown in fig. 3, both gummiferin and atrac- 
tyloside inhibit the mitochoridrial respiration sti- 
mulated by low concentrations of ADP, but where- 
as the inhibition by atractyloside of the ADP-stim- 
ulated respiration is reversed by high ADP concen- 
trations (2 mM) the gummiferin-dependent inhibi- 
tion is not. The effects of both compounds on the 
ADP-stimulated respiration can be taken, in first 
approximation, as indicative of their interference 
with the ADP translocation. 
Fig. 4 points to the specificity of action of gummi- 
ferin which, at concentrations which totally inhibit 
the oxidative phosphorylation of extra-mitoehon- 
drial (I4 C)ADP, does not alter the oxidative phos- 
phorylation of the intra-mitochondrial (12C)-ADP. 
This result indicates that gummiferin prevents the 
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Fig. 5. Relationship between the saturation of the gummiferin 
binding sites and the inhibition of the ADP translocation by 
gummiferin. (1) Adenine-nucleotide translocation: Rat liver 
mitochondria were pm-loaded with (r4C)-adenine nucleo- 
tides asfollows: mitochondria (20 mg/ml of 0.27 M sucrose) 
were incubated with ~3O&I (r4C)-ADP for 15 min at 4” then 
sedimented by centrifugation, washed twice and resuspended 
in 0.27 M sucrose. The labelled mitochondria were then in- 
cubated for 45 min at 2” with different concentrations of 
gummiferin (up to 11.5 PM) in series of tubes (6.6 mg mito- 
chondrial protein per tube) containing 10 ml of 110 mM 
KCl, 6 mM MgClz and 10 mM Tris-sulfate, pH 7.2. The 
adenine-nucleotide translocation assay was then performed 
as follows: 2 r.~, of a 0.5 ml aliquot. The rate of transloca- 
chondrial suspension and the incubation was ended after a 
period of 18-20 set by filtration through millipore filter 
HAWP, 0.45 M, of a 0.5 ml aliquot. The rate of transloca- 
tion in the absence of gummiferin was 6.1 nmole of (14C)- 
ADP/min/mg protein. (2) (3sS)-gummiferin binding: The 
conditions of incubation were similar to those described 
for assessing the adenine-nucleotide translocation. Rat liver 
mitochondria (6.6 mg) were incubated for 45 min at 2” 
with different concentrations of (3sS)-gummiferin (ranging 
from zero to 11.5 fiM) in series of tubes containing 10 ml 
of 110 mM KCl, 6 mM MgCir, 10 mM Tris-sulfate, pH 7.2, 
and 200 I.~M ADP. The incubation was ended by centrifu- 
gation. The mitochondrial pellets were dissolved in 1 ml 
of formamide at 180” and their radioactivity was determined 
by liquid scintillation. 
translocation of external ADP into mitochondria 
without interfering with the coupling mechanism, 
2.3, Binding properties of gummiferin to mitochondtia 
The inhibition of the rate of the ADP transloca- 
tion caused by increasing concentrations of gummi- 
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Fig 6. Scatchard plot of the binding of (3sS)-atractyloside 
and (3sS)-gummiferin to rat liver mitochondria. Same con- 
ditions of incubation as in fig. 5 (2); 8.5 mg of mitochon- 
drial protein per tube. (3sS)atractyloside concentrations: 
up to 0.80 PM (o), from 0.13 PM (0); (3SS)-gummiferin con- 
centrations: up to 0.96 PM. Since, upon incubation and cen- 
trifugation of the mitochondrial suspensions, there is a sub- 
stantial loss of matrix 
(25 to 30%), bound ( 3P 
rotein not recovered in the pellets 
S)-atractyloside and (3sS)-gummi- 
ferin are correlated to cytochrome o. The cytochrome 4 
content of the rat liver mitochondrial preparations used 
was found to be 0.14 f 0.02 nmole of cytochrome a/mg 
protein. 
ferin has been compared to the fractional saturation 
of mitochondria with (3sS)-gummiferin. As shown 
in fig. 5, the saturation curve and the inhibition 
curve are sigmoidal and strictly superimposable. The 
fact that the fractional inhibitory effect of gummi- 
ferin, on the rate of the ADP translocation, is equal 
to the fractional saturation of its binding sites con- 
firms that, in the range of the above mentioned con- 
centrations, gummiferin acts selectively on the ade- 
nine nucleotide transport in mitochondria. 
(35S)gummiferin binding has been compared to 
(3s Qatractyloside binding under equilibrium condi- 
tions, using mitochondrial preparations from differ- 
ent sources [ 181. In this note, results obtained with 
rat liver mitochondria are presented (fig. 6). The 
atractyloside binding curve consists of two typical 
regions. The first region which corresponds to small 
concentrations of added (“S)-atractyloside is charac- 
terized by a steep slope which may reflect either a 
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Fig. 7. Hill plot for saturation of rat liver mitochondria 
with (3sS)-gummiferin. The curve is asymptotic to lines 
of slope 1 at both ends. The total free energy of interac- 
tion between zero and full saturation is calculated from 
the distancey,-yz (intercepts of the asymptotes with 
the Y axis) multiplied by RT [ 201. 
low affinity binding due to a titration, by atrac- 
tyloside [ 111, of the mitochondrial bound ADP 
and ATP or a positive co-operativity. The second 
region exhibits a marked curvature which may be 
interpreted as the result either of negative inter- 
actions or of the presence of more than one class 
of binding sites. Taking the latter alternative re- 
stricted to two classes of independent sites, the 
decomposition of the atractyloside binding curve 
into 2 slopes of low and high affinity allowed us 
to calculate a Kd value of about 15 nM for the 
high affinity sites. 
Whereas the saturation of the atractyloside 
binding sites by (35S)-atractyloside is not yet reach- 
ed at concentrations of inhibitor as high as 27 PM, 
total saturation of mitochondria with ( 35S)-gummi- 
ferin is attained at gummiferin concentrations less 
than 1 PM when using 5 to 8 mg of mitochondrial 
protein. Assuming similar molecular weights for 
atractyloside and gummiferin, a value of 1.6 mole 
of bound gummiferin at saturation per mole of 
cytochrome a was found in the experiment report- 
ed in fig. 6. Values obtained in five experiments 
varied from 1.3 to 1.7 mole of bound gummiferin 
at saturation per mole of cytochrome a, values 
which are in the same range as those reported by 
Weidemann et al. [ 191 for the number of ADP 
binding sites on the ADP carrier. 
The binding of (35S)-gummiferin to mitochon- 
dria is also characterized by strong positive co-op 
erative interactions. Co-operativity indexes higher 
than 2 were usually found. As an example, from 
the Hill plot for saturation of rat liver mitochon- 
dria with (35S)-gummiferin given in fig. 7, a co-op 
erativity index of 4.2 was determined and a total free 
energy of interaction of 2.4 kcal per mole of sites 
at saturation was calculated [20] , using Wyman’s 
convention of making AG, positive when the in- 
teraction is a stabilizing one, i.e. when n> 1. This 
stabilizing energy is to be compared to the total 
free energy (10.3 kcal/mole, calculated from a Kd 
value of 6 nM and at 2”) involved in the binding 
of one mole of gummiferin to rat liver mitochon- 
dria (cf. fig. 9B). 
As evidenced by experiments to be reported 
elsewhere, gummiferin selectively binds to the inner 
mitochondrial membrane as atractyloside does [lo]. 
It is therefore implicit that the gummiferin binding 
properties, as assessed here with whole mitochon- 
dria, concern essentially the inner mitochondrial 
membrane. 
2.4. Effect of ADP 
The binding affinity of mitochondria for atrac- 
tyloside is strikingly decreased by added ADP (fig. 6) 
a result correlative with the fact that ADP in ex- 
cess reverses the inhibitory effect of atractyloside 
on the ADP translocation. On the contrary, ADP 
increases the positive co-operativity for gummiferin 
binding to mitochondria (fig. 6). Previous experi- 
ments carried out with inner mitochondrial mem- 
brane vesicles [ II,21 ] which are virtually depleted 
of phosphotransferases, indicated that the effect of 
ADP on atractyloside binding is not shared by 
other nucleoside diphosphates such as CDP, UDP, 
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Fig. 8. Effect of bongkrekic acid on atractyloside binding to rat liver mitochondria. Mitochondria (8 mg) were preincubated for 
1 min at 20” with bongkrekic acjd at the indicated concentrations in series of tubes containing 10 ml of 110 mM KCI, 6 mM 
MgCls, 10 mM Tris-sulfate, pH 7.2. The tubes were then immediately chilled at 2” and the incubation was started by the addition 
of (35S)-atractyloside or (3sS)-gummiferin. Other conditions as in fig. 6. 
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Fig. 9. Effect of gummiferin on the binding of (3sS)-atractyloside and, reciprocally, of atractyloside on (3sS)-gummiferin binding, 
Labelled and unlabelled inhibitors were incubated together with mitochondria (8 mg protein/tube). Experimental conditions as 
in fig. 6. 
and GDP;-the same observation holds for the effect 
of ADP on gummiferin binding [ 181. 
2.5. Effect of bongkrekic acid 
Bongkrekik acid which has been reported first 
by Henserson and Lardy [22] to inhibit the ADP 
translocation, does not significantly modify the 
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binding affinity of mitochondria for atractyloside the ADP carrier [ 19) ; (3) bound gummiferin is dis- 
and gummiferin but unambiguously depresses the placed by atractyloside and bongkrekic acid, two 
total number of atractyloside or gummiferin bind- other inhibitors of the ADP translocation postulated 
ing sites (fig. 8). to bind to the ADP carrier. 
2.6. Effect of atmctyloside on (3sS)-gwnmiferin 
binding and of gummiferin on (3sS)-atnzctyl- 
oside binding 
Unlabelled atractyloside added in large excess 
together with (3sS)-gummiferin to mitochondria 
significantly diminishes the degree of positive co- 
operativity and the affinity for gummiferin but 
does not interfere with the total amount of bound 
(3s S)-gummiferin at saturation (fig. 9B). Converse- - 
ly, unlabelled gummiferin displaces bound (3sS)- 
atractyloside, but with a much higher efficiency 
than atractyloside does in the case of bound (3s S)- 
gummiferin (fig. 9A). The apparent competitivity 
between atractyloside and gummiferin for binding 
to mitochondria as illustrated in fig. 9 may be con- 
trasted with the non competitive nature of the in- 
hibition, by bongkrekic acid, of the binding of 
atractyloside and gummiferin (fig. 8). 
It is recognized that oligomeric aIlosteric enzymes 
[23] are characterized by homotropic and/or hetero- 
tropic interactions and that the co-operativity index 
relative to ligand binding is indicative of a minimal 
number of sub-units in each oligomer. The results 
presented here favor the concept of an oligomeric 
structure of the ADP carrier which could correspond 
to clusters of translocase units scattered in the inner 
mitochondrial membrane. Along this line it may 
be speculated that the ADP carrier assumes two 
limit interconvertible configurations, one correspond- 
ing to an active form (able to bind and to carry ADP) 
and the other one to an inactive form. The “active” 
form of the carrier would be induced by ADP acting 
both as a substrate for and as an activator of its own 
carrier. On the other hand, gummiferin would in- 
duce a transition from the active to the inactive con- 
figuration and would stabilize it irreversibly. In short, 
ADP and gummiferin may be considered as antago- 
nistic ligands able to displace equilibria between two 
configurations of the ADP carrier. 
3. Discussion 
In spite of their similar structures, as revealed 
by mass spectrometry, gummiferin and atractyloside 
may be discriminated by their inhibitory effects on 
the adenine nucleotide translocation and their bind- 
ing properties to mitochondria. The inhibition of 
the ADP translocation by gummiferin is not reversed 
by high concentrations of ADP, a property which 
is paralleled by the fact that ADP does not displace 
bound (35 S)-gummiferin. In contrast, the inhibition 
of the ADP translocation by atractyloside is of an 
apparent competitive type and the affinity of mito- 
chondrial membranes for (3sS)-atractyloside is de- 
creased by added ADP. 
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